Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -1.72% is 68% above its 5-year average of -5.32%, around the middle of its 5-year range (-21.44%–26.40%).
20.13% above its 12-month average of -2.15%.
Reported quarterly operating margin; no daily interpolation. Q1 FY2027 (2026-07-31): -2.69%.
OPERATING MARGIN
-1.72%
OPERATING MARGIN AVG TTM
-2.15%
OPERATING MARGIN AVG 3Y
-5.86%
OPERATING MARGIN AVG 5Y
-5.32%
OPERATING MARGIN AVG 10Y
-4.24%
OPERATING MARGIN AVG 15Y
-29.28%
OPERATING MARGIN AVG 20Y
-32.68%
CURRENT VS TTM AVG
+20.13%
CURRENT VS 3Y AVG
+70.66%
CURRENT VS 5Y AVG
+67.65%
CURRENT VS 10Y AVG
+59.46%
CURRENT VS 15Y AVG
+94.13%
CURRENT VS 20Y AVG
+94.74%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 745 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Champions Oncology, Inc.
Market Cap
$67.38M
Operating Margin
-1.72%
TTM Avg
-2.15%
3Y Avg
-5.86%
5Y Avg
-5.32%
Market Cap
$68.60M
Operating Margin
-111.00%
TTM Avg
-151.19%
3Y Avg
-184.89%
5Y Avg
-203.40%
Market Cap
$66.23M
Operating Margin
-1113.98%
TTM Avg
-13312.81%
3Y Avg
-6656.40%
5Y Avg
-4437.60%
Market Cap
$69.45M
Operating Margin
-35141.00%
TTM Avg
-19895.75%
3Y Avg
-11796.10%
5Y Avg
-8345.47%
Market Cap
$64.85M
Operating Margin
-7.19%
TTM Avg
-4.82%
3Y Avg
-64.73%
5Y Avg
-128.10%
Market Cap
$64.83M
Operating Margin
-336.81%
TTM Avg
-194.53%
3Y Avg
-97.26%
5Y Avg
-64.84%
Market Cap
$70.48M
Operating Margin
-96.01%
TTM Avg
-72.88%
3Y Avg
-81.45%
5Y Avg
-72.54%
Market Cap
$63.78M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-3242.03%
5Y Avg
-2392.63%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Champions Oncology, Inc. (CSBR) | $67.38M | -1.72% | -2.15% | -5.86% | -5.32% |
| Fortress Biotech, Inc. (FBIO)vs › | $68.60M | -111.00% | -151.19% | -184.89% | -203.40% |
| Cingulate Inc. (CING)vs › | $65.79M | 0.00% | 0.00% | 0.00% | 0.00% |
| RenovoRx, Inc. (RNXT)vs › | $66.23M | -1113.98% | -13312.81% | -6656.40% | -4437.60% |
| iBio, Inc. (IBIO)vs › | $69.45M | -35141.00% | -19895.75% | -11796.10% | -8345.47% |
| Heron Therapeutics, Inc. (HRTX)vs › | $64.85M | -7.19% | -4.82% | -64.73% | -128.10% |
| Gossamer Bio, Inc. (GOSS)vs › | $64.83M | -336.81% | -194.53% | -97.26% | -64.84% |
| MindWalk Holdings Corp. (HYFT)vs › | $70.48M | -96.01% | -72.88% | -81.45% | -72.54% |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.78M | 0.00% | 0.00% | -3242.03% | -2392.63% |
| Alps Group Inc (ALPS)vs › | $63.23M | -69.62% | -71.11% | -78.39% | -54.75% |
Gross Margin
49.3%
Operating Margin
-1.7%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-07-31 | -2.69% |
| 2026-04-30 | -4.56% |
| 2026-01-31 | -1.13% |
| 2025-10-31 | 1.23% |
| 2025-07-31 | -3.62% |
| 2025-04-30 | -13.87% |
| 2025-01-31 | 26.40% |
| 2024-10-31 | 5.43% |
| 2024-07-31 | 9.45% |
| 2024-04-30 | -1.94% |
| 2024-01-31 | -21.44% |
| 2023-10-31 | -16.89% |
| 2023-07-31 | -20.32% |
| 2023-04-30 | -19.29% |
| 2023-01-31 | -19.24% |
| 2022-10-31 | 0.05% |
| 2022-07-31 | -2.07% |
| 2022-04-30 | -2.42% |
| 2022-01-31 | 6.29% |
| 2021-10-31 | 2.23% |
| 2021-07-31 | -1.56% |
| 2021-04-30 | -4.06% |
| 2021-01-31 | 9.08% |
| 2020-10-31 | 0.07% |
| 2020-07-31 | 0.25% |
| 2020-04-30 | -21.86% |
| 2020-01-31 | 4.80% |
| 2019-10-31 | 3.82% |
| 2019-07-31 | -9.11% |
| 2019-04-30 | -1.50% |
| 2019-01-31 | -5.75% |
| 2018-10-31 | 4.11% |
| 2018-07-31 | 7.73% |
| 2018-04-30 | -12.17% |
| 2018-01-31 | -1.32% |
| 2017-10-31 | -1.35% |
| 2017-07-31 | -12.30% |
| 2017-04-30 | -64.22% |
| 2017-01-31 | -39.30% |
| 2016-10-31 | -11.06% |
| 2016-07-31 | -68.75% |
| 2016-04-30 | -89.85% |
| 2016-01-31 | -92.99% |
| 2015-10-31 | -83.91% |
| 2015-07-31 | -102.66% |
| 2015-04-30 | -74.17% |
| 2015-01-31 | -186.93% |
| 2014-10-31 | -194.79% |
| 2014-07-31 | -195.03% |
| 2014-04-30 | -96.75% |
| 2014-01-31 | -38.16% |
| 2013-10-31 | -71.38% |
| 2013-07-31 | -25.36% |
| 2013-04-30 | -107.82% |
| 2013-01-31 | -24.68% |
| 2012-10-31 | -131.41% |
| 2012-07-31 | -75.93% |
| 2012-04-30 | -188.41% |
| 2012-01-31 | -74.00% |
| 2011-10-31 | -141.82% |
| 2011-07-31 | -135.50% |
| 2011-04-30 | -183.35% |
| 2011-01-31 | -28.02% |
| 2010-10-31 | -108.79% |
| 2010-07-31 | -37.69% |
| 2010-04-30 | -29.05% |
| 2010-01-31 | -105.66% |
| 2009-10-31 | -45.31% |
| 2009-07-31 | -104.78% |
| 2009-04-30 | -131.93% |
| 2009-01-31 | -59.35% |
| 2008-10-31 | -24.58% |
| 2008-07-31 | -22.59% |
| 2008-04-30 | -200.61% |
| 2008-01-31 | 65.40% |
| 2007-10-31 | 0.00% |
| 2007-07-31 | 1.28% |
| 2007-04-30 | 0.00% |
| 2007-01-31 | 0.00% |
| 2006-10-31 | 0.00% |
| 2006-07-31 | 0.00% |
| 2006-04-30 | 0.00% |
| 2006-01-31 | 0.00% |
| 2005-10-31 | 0.00% |
| 2005-07-31 | 0.00% |
| 2005-04-30 | 0.84% |
| 2005-01-31 | 14.74% |
| 2004-10-31 | -16.55% |
| 2004-07-31 | -12.86% |
| 2004-04-30 | 1.56% |
| 2004-01-31 | -11.68% |
| 2003-10-31 | -7.06% |
| 2003-07-31 | -8.72% |
| 2003-04-30 | -13.11% |
| 2003-01-31 | -9.57% |
| 2002-10-31 | 6.67% |
